Cargando…

5-Aza-dC suppresses melanoma progression by inhibiting GAS5 hypermethylation

The in-depth study of melanoma pathogenesis has revealed that epigenetic modifications, particularly DNA methylation, is a universal inherent feature of the development and progression of melanoma. In the present study, the analysis of the tumor suppressor gene growth arrest-specific transcript 5 (G...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yang-Jie, Xie, Ran, Jiang, Jie, Zhai, Li, Yang, Cong-Hui, Zhang, Jing, Wang, Xi, Chen, Dong-Xue, Niu, Hua-Tao, Chen, Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164261/
https://www.ncbi.nlm.nih.gov/pubmed/35593315
http://dx.doi.org/10.3892/or.2022.8334
_version_ 1784720096858472448
author Zhang, Yang-Jie
Xie, Ran
Jiang, Jie
Zhai, Li
Yang, Cong-Hui
Zhang, Jing
Wang, Xi
Chen, Dong-Xue
Niu, Hua-Tao
Chen, Long
author_facet Zhang, Yang-Jie
Xie, Ran
Jiang, Jie
Zhai, Li
Yang, Cong-Hui
Zhang, Jing
Wang, Xi
Chen, Dong-Xue
Niu, Hua-Tao
Chen, Long
author_sort Zhang, Yang-Jie
collection PubMed
description The in-depth study of melanoma pathogenesis has revealed that epigenetic modifications, particularly DNA methylation, is a universal inherent feature of the development and progression of melanoma. In the present study, the analysis of the tumor suppressor gene growth arrest-specific transcript 5 (GAS5) demonstrated that its expression was downregulated in melanoma, and its expression level had a certain negative association with its methylation modification level. The promoter of GAS5 presented with detectable CpG islands, and methylation-specific polymerase chain reaction analysis demonstrated that GAS5 was actually modified by methylation in melanoma tissues and cells; however, no methylation modification of GAS5 was detected in normal tissues. Following the treatment of melanoma cells with 5-Aza-2′-deoxycytidine (5-Aza-dC), GAS5 methylation was significantly reversed. The analysis of melanoma cell proliferation revealed that 5-Aza-dC inhibited A375 and SK-MEL-110 cell proliferation in a time-dependent manner. Further analysis of apoptosis demonstrated that 5-Aza-dC significantly increased the apoptosis level of the two cell lines. Moreover, migration analysis of melanoma cells revealed that 5-Aza-dC significantly reduced cell migration. Furthermore, 5-Aza-dC significantly decreased the invasive ability of the two cell lines. However, when the expression of GAS5 was silenced, the effects of 5-Aza-dC on cell proliferation, apoptosis, invasion and migration were not significant. Furthermore, the subcutaneous injection of A375 cells in nude mice successfully resulted in xenograft tumor formation. However, following an intraperitoneal injection of 5-Aza-dC, the volume and weight of xenograft tumors and Ki-67 expression were significantly reduced, and caspase-3 activity and GAS5 expression were enhanced; following the silencing of GAS5, the antitumor effect of 5-Aza-dC was significantly blocked. On the whole, the present study demonstrates that 5-Aza-dC inhibits the growth of melanoma, and its function may be related to the methylation modification of GAS5.
format Online
Article
Text
id pubmed-9164261
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-91642612022-06-10 5-Aza-dC suppresses melanoma progression by inhibiting GAS5 hypermethylation Zhang, Yang-Jie Xie, Ran Jiang, Jie Zhai, Li Yang, Cong-Hui Zhang, Jing Wang, Xi Chen, Dong-Xue Niu, Hua-Tao Chen, Long Oncol Rep Articles The in-depth study of melanoma pathogenesis has revealed that epigenetic modifications, particularly DNA methylation, is a universal inherent feature of the development and progression of melanoma. In the present study, the analysis of the tumor suppressor gene growth arrest-specific transcript 5 (GAS5) demonstrated that its expression was downregulated in melanoma, and its expression level had a certain negative association with its methylation modification level. The promoter of GAS5 presented with detectable CpG islands, and methylation-specific polymerase chain reaction analysis demonstrated that GAS5 was actually modified by methylation in melanoma tissues and cells; however, no methylation modification of GAS5 was detected in normal tissues. Following the treatment of melanoma cells with 5-Aza-2′-deoxycytidine (5-Aza-dC), GAS5 methylation was significantly reversed. The analysis of melanoma cell proliferation revealed that 5-Aza-dC inhibited A375 and SK-MEL-110 cell proliferation in a time-dependent manner. Further analysis of apoptosis demonstrated that 5-Aza-dC significantly increased the apoptosis level of the two cell lines. Moreover, migration analysis of melanoma cells revealed that 5-Aza-dC significantly reduced cell migration. Furthermore, 5-Aza-dC significantly decreased the invasive ability of the two cell lines. However, when the expression of GAS5 was silenced, the effects of 5-Aza-dC on cell proliferation, apoptosis, invasion and migration were not significant. Furthermore, the subcutaneous injection of A375 cells in nude mice successfully resulted in xenograft tumor formation. However, following an intraperitoneal injection of 5-Aza-dC, the volume and weight of xenograft tumors and Ki-67 expression were significantly reduced, and caspase-3 activity and GAS5 expression were enhanced; following the silencing of GAS5, the antitumor effect of 5-Aza-dC was significantly blocked. On the whole, the present study demonstrates that 5-Aza-dC inhibits the growth of melanoma, and its function may be related to the methylation modification of GAS5. D.A. Spandidos 2022-05-19 /pmc/articles/PMC9164261/ /pubmed/35593315 http://dx.doi.org/10.3892/or.2022.8334 Text en Copyright: © Zhang et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Zhang, Yang-Jie
Xie, Ran
Jiang, Jie
Zhai, Li
Yang, Cong-Hui
Zhang, Jing
Wang, Xi
Chen, Dong-Xue
Niu, Hua-Tao
Chen, Long
5-Aza-dC suppresses melanoma progression by inhibiting GAS5 hypermethylation
title 5-Aza-dC suppresses melanoma progression by inhibiting GAS5 hypermethylation
title_full 5-Aza-dC suppresses melanoma progression by inhibiting GAS5 hypermethylation
title_fullStr 5-Aza-dC suppresses melanoma progression by inhibiting GAS5 hypermethylation
title_full_unstemmed 5-Aza-dC suppresses melanoma progression by inhibiting GAS5 hypermethylation
title_short 5-Aza-dC suppresses melanoma progression by inhibiting GAS5 hypermethylation
title_sort 5-aza-dc suppresses melanoma progression by inhibiting gas5 hypermethylation
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164261/
https://www.ncbi.nlm.nih.gov/pubmed/35593315
http://dx.doi.org/10.3892/or.2022.8334
work_keys_str_mv AT zhangyangjie 5azadcsuppressesmelanomaprogressionbyinhibitinggas5hypermethylation
AT xieran 5azadcsuppressesmelanomaprogressionbyinhibitinggas5hypermethylation
AT jiangjie 5azadcsuppressesmelanomaprogressionbyinhibitinggas5hypermethylation
AT zhaili 5azadcsuppressesmelanomaprogressionbyinhibitinggas5hypermethylation
AT yangconghui 5azadcsuppressesmelanomaprogressionbyinhibitinggas5hypermethylation
AT zhangjing 5azadcsuppressesmelanomaprogressionbyinhibitinggas5hypermethylation
AT wangxi 5azadcsuppressesmelanomaprogressionbyinhibitinggas5hypermethylation
AT chendongxue 5azadcsuppressesmelanomaprogressionbyinhibitinggas5hypermethylation
AT niuhuatao 5azadcsuppressesmelanomaprogressionbyinhibitinggas5hypermethylation
AT chenlong 5azadcsuppressesmelanomaprogressionbyinhibitinggas5hypermethylation